---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-002842"
form_type: "8-K"
ticker: "ENTXW"
cik: "0001638097"
company_name: "Entera Bio Ltd."
filed_at: "2022-08-01T23:59:59+00:00"
generated_at: "2026-06-24T06:30:57.777040+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Entera Bio releases updated corporate presentation; no specific new financial data

## Summary
- Updated corporate presentation made available on August 1, 2022, on company website.
- Exhibit 99.1 included but text truncated; no financial metrics or guidance changes extracted.
- Presentation likely covers pipeline and business overview; no material events announced.
- Stock tickers: ENTX (ordinary shares) and ENTXW (warrants).

## SEC filing metadata
- accession: 0001178913-22-002842
- form_type: 8-K
- ticker: ENTXW
- cik: 0001638097
- company_name: Entera Bio Ltd.
- filed_at: 2022-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002842/0001178913-22-002842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638097/000117891322002842/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-002842
- JSON: https://secwatch.observer/filing/0001178913-22-002842.json
- Plain text: https://secwatch.observer/filing/0001178913-22-002842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.